PC
NEUE

Provenire Capital’s NeueHealth NEUE Stock Holding History

Provenire Capital’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$486K Buy
745
+120
+19% +$106K 1.79% 25
2021
Q2 		$858K Buy
+625
New +$856K 2.9% 12

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DIC
Deer IX & Co Larchmont, New York $971M AUM 24.77% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.35B AUM 27.53% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Provenire Capital's NEUE Position: Q3 2021 in Review

Provenire Capital increased its NeueHealth (NEUE) stake by 19% in Q3 2021, buying an estimated $106K and bringing the position to 745 shares worth $486K. The position accounts for 1.79% of the portfolio, ranked #25.

Provenire Capital first reported a position in NEUE in Q2 2021 and has held it in 2 quarters since. The position peaked at $858K in Q2 2021. 101 funds tracked by Wall St. Rank hold NEUE as of Q3 2021.

  • Provenire Capital held 745 shares of NeueHealth worth $486K as of Q3 2021.
  • Provenire Capital bought 120 NeueHealth shares in Q3 2021, an estimated $106K.
  • NeueHealth made up 1.79% of Provenire Capital's portfolio in Q3 2021, its #25 holding.
  • Provenire Capital first reported a position in NeueHealth in Q2 2021 and has held it in 2 quarters since.
  • Provenire Capital's NeueHealth position peaked at $858K in Q2 2021.
  • 101 funds tracked by Wall St. Rank held NeueHealth as of Q3 2021.

Based on Provenire Capital's 13F filing for Q3 2021, filed 15 Nov 2021.